Why did a German newspaper insist the Oxford AstraZeneca vaccine was inefficacious for older people—without evidence?

@article{Boytchev2021WhyDA,
  title={Why did a German newspaper insist the Oxford AstraZeneca vaccine was inefficacious for older people—without evidence?},
  author={Hristio Boytchev},
  journal={BMJ},
  year={2021},
  volume={372}
}
Reporting information from single anonymous sources that turns out to be false could erode public confidence in the vaccines that are crucial to controlling the covid-19 pandemic. Hristio Boytchev reports 
The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland
TLDR
The study shows the level of trust in COVID-19 vaccines can vary much across the producers while the mRNA vaccines are received with a high level of acceptance and emphasizes the need for effective and continuous science communication when fighting the pandemic. Expand
Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy
TLDR
Taking into consideration the factors involved in vaccine hesitancy/resistance in college students could represent a key public health strategy to increase vaccine coverage and reduce viral spreading. Expand
Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers
TLDR
Females and the younger age group were associated with an increased risk of side effects either after mRNA-based or viral vector-based vaccines, and the gender- and age-based differences warrant further rigorous investigation and standardized methodology. Expand
Changes in Attitudes and Beliefs Concerning Vaccination and Influenza Vaccines between the First and Second COVID-19 Pandemic Waves: A Longitudinal Study
TLDR
Previous influenza vaccinations, receipt of a COVID-19 vaccine, positive attitudes towards (influenza) vaccination, male sex, and older age were the main correlates of willingness to receive the 2021/22 influenza vaccine. Expand
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases
  • A. Kronbichler, H. Anders, +7 authors A. Bruchfeld
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2021
Abstract Coronavirus Disease 19 (COVID-19) vaccine platforms are becoming available and are the most promising strategy to curb the spread of SARS-CoV-2 infections. However, numerous uncertaintiesExpand

References

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
TLDR
ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. Expand